Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""IMMUNOGLOBULINS"" wg kryterium: Temat


Starter badań:

Tytuł :
High-dose intravenous immunoglobulins might modulate inflammation in COVID-19 patients.
Autorzy :
Rodríguez de la Concepción ML; IrsiCaixa AIDS Research Institute, Germans Trias i Pujol Research Institute (IGTP), Can Ruti Campus, Badalona, Spain.
Ainsua-Enrich E; IrsiCaixa AIDS Research Institute, Germans Trias i Pujol Research Institute (IGTP), Can Ruti Campus, Badalona, Spain.
Reynaga E; Infectious Diseases Department, Fight Against AIDS Foundation (FLS), Germans Trias i Pujol Hospital, Badalona, Spain.
Ávila-Nieto C; IrsiCaixa AIDS Research Institute, Germans Trias i Pujol Research Institute (IGTP), Can Ruti Campus, Badalona, Spain.
Santos JR; Infectious Diseases Department, Fight Against AIDS Foundation (FLS), Germans Trias i Pujol Hospital, Badalona, Spain.
Roure S; Infectious Diseases Department, Fight Against AIDS Foundation (FLS), Germans Trias i Pujol Hospital, Badalona, Spain.
Mateu L; Infectious Diseases Department, Fight Against AIDS Foundation (FLS), Germans Trias i Pujol Hospital, Badalona, Spain.; Universitat Autonoma de Barcelona, Cerdanyola Del Vallès, Spain.; CIBERes: Centro de investigaciones en Red de Enfermedades Respiratorias Del Instituto Carlos III, Madrid, Spain.
Paredes R; IrsiCaixa AIDS Research Institute, Germans Trias i Pujol Research Institute (IGTP), Can Ruti Campus, Badalona, Spain.; Infectious Diseases Department, Fight Against AIDS Foundation (FLS), Germans Trias i Pujol Hospital, Badalona, Spain.
Puig J; Infectious Diseases Department, Fight Against AIDS Foundation (FLS), Germans Trias i Pujol Hospital, Badalona, Spain.
Jimenez JM; Infectious Diseases Department, Fight Against AIDS Foundation (FLS), Germans Trias i Pujol Hospital, Badalona, Spain.
Izquierdo-Useros N; IrsiCaixa AIDS Research Institute, Germans Trias i Pujol Research Institute (IGTP), Can Ruti Campus, Badalona, Spain.
Clotet B; IrsiCaixa AIDS Research Institute, Germans Trias i Pujol Research Institute (IGTP), Can Ruti Campus, Badalona, Spain.; Infectious Diseases Department, Fight Against AIDS Foundation (FLS), Germans Trias i Pujol Hospital, Badalona, Spain.; Chair in Infectious Diseases and Immunity, Centre for Health and Social Care Research (CESS), Faculty of Medicine. University of Vic-Central University of Catalonia (UVic-UCC), Vic, Spain.; Universitat Autonoma de Barcelona, Cerdanyola Del Vallès, Spain.; CIBERes: Centro de investigaciones en Red de Enfermedades Respiratorias Del Instituto Carlos III, Madrid, Spain.
Pedro-Botet ML; Infectious Diseases Department, Fight Against AIDS Foundation (FLS), Germans Trias i Pujol Hospital, Badalona, Spain.; Universitat Autonoma de Barcelona, Cerdanyola Del Vallès, Spain.; CIBERes: Centro de investigaciones en Red de Enfermedades Respiratorias Del Instituto Carlos III, Madrid, Spain.
Carrillo J; IrsiCaixa AIDS Research Institute, Germans Trias i Pujol Research Institute (IGTP), Can Ruti Campus, Badalona, Spain .
Pokaż więcej
Źródło :
Life science alliance [Life Sci Alliance] 2021 Jul 28; Vol. 4 (9). Date of Electronic Publication: 2021 Jul 28 (Print Publication: 2021).
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
COVID-19/*therapy
Immunoglobulins, Intravenous/*therapeutic use
Administration, Intravenous ; Adult ; Aged ; Biomarkers/blood ; COVID-19/blood ; COVID-19/immunology ; COVID-19/virology ; Chemokines/blood ; Cytokines/blood ; Female ; Humans ; Immunity/immunology ; Immunoglobulins/immunology ; Immunoglobulins/therapeutic use ; Immunoglobulins, Intravenous/immunology ; Inflammation/blood ; Inflammation/therapy ; Inflammation/virology ; Male ; Middle Aged ; SARS-CoV-2/isolation & purification
Czasopismo naukowe
Tytuł :
The Importance of Early Recognition, Timely Management, and the Role of Healthcare Providers in Multisystem Inflammatory Syndrome in Children.
Autorzy :
Lee JH; Department of Pediatrics, College of Medicine, Chungbuk National University, Cheongju, Korea.; Department of Pediatrics, Chungbuk National University Hospital, Cheongju, Korea.
Han HS; Department of Pediatrics, College of Medicine, Chungbuk National University, Cheongju, Korea.; Department of Pediatrics, Chungbuk National University Hospital, Cheongju, Korea.
Lee JK; Department of Pediatrics, Chungbuk National University Hospital, Cheongju, Korea.; Department of Infection Control and Prevention, Chungbuk National University Hospital, Cheongju, Korea. .
Pokaż więcej
Źródło :
Journal of Korean medical science [J Korean Med Sci] 2021 Jan 11; Vol. 36 (2), pp. e17. Date of Electronic Publication: 2021 Jan 11.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Systemic Inflammatory Response Syndrome*/diagnosis
Systemic Inflammatory Response Syndrome*/pathology
Systemic Inflammatory Response Syndrome*/therapy
COVID-19/*pathology
COVID-19/*therapy
Immunoglobulins, Intravenous/*therapeutic use
Antibodies, Viral/therapeutic use ; COVID-19/diagnosis ; Child ; Humans ; Immunization, Passive/methods ; Immunoglobulins/administration & dosage ; Immunoglobulins/therapeutic use ; Male ; Republic of Korea ; SARS-CoV-2/immunology ; Treatment Outcome
SCR Disease Name :
pediatric multisystem inflammatory disease, COVID-19 related
Czasopismo naukowe
Tytuł :
Adverse reactions in a large cohort of patients with inborn errors of immunity receiving intravenous immunoglobulin.
Autorzy :
Esmaeilzadeh H; Allergy Research Center, Shiraz University of Medical Sciences, Shiraz, Iran; Division of Allergy and Clinical Immunology, Pediatrics Department, Shiraz University of Medical Sciences, Shiraz, Iran.
Askarisarvestani A; Division of Allergy and Clinical Immunology, Pediatrics Department, Shiraz University of Medical Sciences, Shiraz, Iran.
Hosseini N; Research Center for Immunodeficiencies, Pediatrics Center of Excellence, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran.
Samimi S; Research Center for Immunodeficiencies, Pediatrics Center of Excellence, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran; Primary Immunodeficiency Diseases Network (PIDNet), Universal Scientific Education and Research Network (USERN), Tehran, Iran.
Shafiei A; Division of Allergy and Clinical Immunology, Department of Pediatrics, Bahrami Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Mahdaviani SA; Pediatric Respiratory Diseases Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Eslami N; Allergy and Clinical immunology Dept, Mofid Children Hospital, , Shahid Beheshti University of Medical Sciences, Tehran, , Iran.
Chavoshzadeh Z; Allergy and Clinical immunology Dept, Mofid Children Hospital, , Shahid Beheshti University of Medical Sciences, Tehran, , Iran.
Fallahi M; Allergy and Clinical immunology Dept, Mofid Children Hospital, , Shahid Beheshti University of Medical Sciences, Tehran, , Iran.
Khakbazanfard N; Allergy and Clinical immunology Dept, Mofid Children Hospital, , Shahid Beheshti University of Medical Sciences, Tehran, , Iran.
Shabestari MS; Department of Immunology and Allergy, Tabriz University of Medical Sciences, Tabriz, Iran.
Aleyasin S; Allergy Research Center, Shiraz University of Medical Sciences, Shiraz, Iran; Division of Allergy and Clinical Immunology, Pediatrics Department, Shiraz University of Medical Sciences, Shiraz, Iran.
Nabavizadeh SH; Allergy Research Center, Shiraz University of Medical Sciences, Shiraz, Iran; Division of Allergy and Clinical Immunology, Pediatrics Department, Shiraz University of Medical Sciences, Shiraz, Iran.
Cheraghi T; Department of Pediatrics, 17th Shahrivar Children's Hospital, Guilan University of Medical Sciences, Rasht, Iran.
Kalantari A; Department of Immunology and Allergy, Imam Khomeini Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Ahmadiafshar A; Mousavi Hospital, Zanjan University of Medical Sciences, Zanjan, Iran.
Safari M; Department of Pediatrics, Hamadan University of Medical Sciences, Hamadan, Iran.
Eslamian MH; Department of Pediatrics, Hamadan University of Medical Sciences, Hamadan, Iran.
Molatefi R; Department of Pediatrics, Bo-Ali children's Hospital of Ardabil University of Medical Sciences, Ardabil, Iran.
Shirkani A; Allergy and Clinical Immunology Department, Bushehr University of Medical Science, School of Medicine, Bushehr, Iran.
Heidarzadeh Arani M; Pediatric Department, School of Medicine, Kashan University of Medical Sciences, Kashan, Iran.
Tavakol M; Non-Communicable Diseases Research Center, Alborz University of Medical Sciences, Karaj, Iran.
Bemanian MH; Department of Allergy and Clinical Immunology, Rasool e Akram Hospital, Iran University of Medical Sciences, Tehran, Iran.
Arshi S; Department of Allergy and Clinical Immunology, Rasool e Akram Hospital, Iran University of Medical Sciences, Tehran, Iran.
Nabavi M; Department of Allergy and Clinical Immunology, Rasool e Akram Hospital, Iran University of Medical Sciences, Tehran, Iran.
Shokri S; Department of Allergy and Clinical Immunology, Rasool e Akram Hospital, Iran University of Medical Sciences, Tehran, Iran.
Shahhosseini B; Division of Allergy and Clinical Immunology, Pediatrics Department, Shiraz University of Medical Sciences, Shiraz, Iran.
Mortazavi N; Department of Clinical Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran.
Nakhaei P; Research Center for Immunodeficiencies, Pediatrics Center of Excellence, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran.
Nazari F; Research Center for Immunodeficiencies, Pediatrics Center of Excellence, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran; Primary Immunodeficiency Diseases Network (PIDNet), Universal Scientific Education and Research Network (USERN), Tehran, Iran.
Fallahpour M; Department of Allergy and Clinical Immunology, Rasool e Akram Hospital, Iran University of Medical Sciences, Tehran, Iran.
Ahanchian H; Allergy Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
Moazzen N; Allergy Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
Khoshkhui M; Allergy Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
Motlagh AV; Department of Pediatrics, North Khorasan University of Medical Sciences, Bojnurd. Iran.
Aghamohammadi A; Research Center for Immunodeficiencies, Pediatrics Center of Excellence, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran; Primary Immunodeficiency Diseases Network (PIDNet), Universal Scientific Education and Research Network (USERN), Tehran, Iran.
Abolhassani H; Research Center for Immunodeficiencies, Pediatrics Center of Excellence, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran; Division of Clinical Immunology, Department of Biosciences and Nutrition, Karolinska Institute, Stockholm, Sweden; Division of Clinical Immunology, Department of Laboratory Medicine, Karolinska Institute at Karolinska University Hospital Huddinge, Stockholm, Sweden; Primary Immunodeficiency Diseases Network (PIDNet), Universal Scientific Education and Research Network (USERN), Tehran, Iran.
Yazdani R; Research Center for Immunodeficiencies, Pediatrics Center of Excellence, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran; Primary Immunodeficiency Diseases Network (PIDNet), Universal Scientific Education and Research Network (USERN), Tehran, Iran.
Rezaei N; Research Center for Immunodeficiencies, Pediatrics Center of Excellence, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran; Primary Immunodeficiency Diseases Network (PIDNet), Universal Scientific Education and Research Network (USERN), Tehran, Iran. Electronic address: .
Pokaż więcej
Źródło :
Clinical immunology (Orlando, Fla.) [Clin Immunol] 2021 Sep; Vol. 230, pp. 108826. Date of Electronic Publication: 2021 Aug 19.
Typ publikacji :
Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
MeSH Terms :
Immunoglobulins, Intravenous/*adverse effects
Immunologic Deficiency Syndromes/*genetics
Immunologic Deficiency Syndromes/*therapy
Adolescent ; Adult ; Agammaglobulinemia/genetics ; Agammaglobulinemia/immunology ; Agammaglobulinemia/therapy ; Aged ; Ataxia Telangiectasia/genetics ; Ataxia Telangiectasia/immunology ; Ataxia Telangiectasia/therapy ; Child ; Child, Preschool ; Cohort Studies ; Common Variable Immunodeficiency/genetics ; Common Variable Immunodeficiency/immunology ; Common Variable Immunodeficiency/therapy ; Female ; Humans ; Immunoglobulins, Intravenous/administration & dosage ; Immunologic Deficiency Syndromes/immunology ; Infant ; Infusions, Intravenous ; Male ; Middle Aged ; Young Adult
Czasopismo naukowe
Tytuł :
A single center experience of intravenous immunoglobulin treatment in Covid-19.
Autorzy :
Omma A; Ministry of Health Ankara City Hospital, Clinic of Rheumatology, Ankara 06800, Turkey.
Erden A; Ministry of Health Ankara City Hospital, Clinic of Rheumatology, Ankara 06800, Turkey.
Armağan B; Ministry of Health Ankara City Hospital, Clinic of Rheumatology, Ankara 06800, Turkey.
Güven SC; Ministry of Health Ankara City Hospital, Clinic of Rheumatology, Ankara 06800, Turkey. Electronic address: .
Karakaş Ö; Ministry of Health Ankara City Hospital, Clinic of Rheumatology, Ankara 06800, Turkey.
Şahiner ES; Ministry of Health Ankara City Hospital, Clinic of Internal Medicine, Ankara 06800, Turkey.
Erdem D; University of Health Sciences, School of Medicine, Ankara City Hospital, Department of Anesthesia and Resuscitation, Ankara 06800, Turkey.
İzdeş S; Yıldırım Beyazıt University, School of Medicine, Department of Anesthesiology and Reanimation-Critical Care, Ankara 06800, Turkey.
Ateş İ; University of Health Sciences, School of Medicine, Ankara City Hospital, Department of Internal Medicine, Ankara 06800, Turkey.
Küçükşahin O; Yıldırım Beyazıt University, School of Medicine, Department of Internal Medicine, Division of Rheumatology, Ankara 06800, Turkey.
Pokaż więcej
Źródło :
International immunopharmacology [Int Immunopharmacol] 2021 Sep; Vol. 98, pp. 107891. Date of Electronic Publication: 2021 Jun 14.
Typ publikacji :
Journal Article; Observational Study
MeSH Terms :
COVID-19/*drug therapy
Immunoglobulins, Intravenous/*administration & dosage
Administration, Intravenous ; Adult ; Aged ; Aged, 80 and over ; COVID-19/diagnosis ; COVID-19/mortality ; COVID-19/virology ; Cross-Sectional Studies ; Female ; Humans ; Immunoglobulins, Intravenous/adverse effects ; Male ; Middle Aged ; Retrospective Studies ; Severity of Illness Index ; Time Factors ; Treatment Outcome ; Turkey
SCR Protocol :
COVID-19 drug treatment
Czasopismo naukowe
Tytuł :
Intravenous immunoglobulin as the rescue treatment in NMOSD patients.
Autorzy :
Lin J; Department of Neurology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
Xue B; Department of Anesthesiology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
Zhu R; Department of Neurology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
Pan J; Department of Neurology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
Li J; Department of Neurology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
Lin Y; Department of Neurology, The Second Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
Li X; Department of Neurology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China. .
Xia J; Department of Neurology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China. .
Pokaż więcej
Źródło :
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology [Neurol Sci] 2021 Sep; Vol. 42 (9), pp. 3857-3863. Date of Electronic Publication: 2021 Feb 01.
Typ publikacji :
Journal Article
MeSH Terms :
Immunoglobulins, Intravenous*/therapeutic use
Neuromyelitis Optica*/drug therapy
Aquaporin 4 ; Autoantibodies ; Humans ; Methylprednisolone/therapeutic use ; Recurrence ; Retrospective Studies
Czasopismo naukowe
Tytuł :
Impact of subcutaneous immunoglobulin on quality of life in patients with chronic inflammatory demyelinating polyneuropathy previously treated with intravenous immunoglobulin.
Autorzy :
Vu T; GBS/CIDP Center of Excellence, University of South Florida, Tampa, Florida, USA.
Anthony N; GBS/CIDP Center of Excellence, University of South Florida, Tampa, Florida, USA.
Alsina R; GBS/CIDP Center of Excellence, University of South Florida, Tampa, Florida, USA.
Harvey B; GBS/CIDP Center of Excellence, University of South Florida, Tampa, Florida, USA.
Schleutker A; GBS/CIDP Center of Excellence, University of South Florida, Tampa, Florida, USA.
Farias J; GBS/CIDP Center of Excellence, University of South Florida, Tampa, Florida, USA.
Dang S; GBS/CIDP Center of Excellence, University of South Florida, Tampa, Florida, USA.
Suresh N; GBS/CIDP Center of Excellence, University of South Florida, Tampa, Florida, USA.
Gooch C; GBS/CIDP Center of Excellence, University of South Florida, Tampa, Florida, USA.
Pokaż więcej
Źródło :
Muscle & nerve [Muscle Nerve] 2021 Sep; Vol. 64 (3), pp. 351-357. Date of Electronic Publication: 2021 Jun 15.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Immunoglobulin G/*therapeutic use
Immunoglobulins, Intravenous/*therapeutic use
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating/*drug therapy
Quality of Life/*psychology
Adult ; Aged ; Female ; Humans ; Immunoglobulin G/administration & dosage ; Immunoglobulins, Intravenous/administration & dosage ; Infusions, Subcutaneous ; Male ; Middle Aged ; Patient Satisfaction ; Retreatment ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Adjunct Immune Globulin for Vaccine-Induced Immune Thrombotic Thrombocytopenia.
Autorzy :
Bourguignon A; From the Departments of Medicine (A.B., D.M.A., T.E.W., J.W.S., Z.A.A.A.M., A.S., J.G.K., I.N.) and Pathology and Molecular Medicine (A.B., T.E.W.), Michael G. DeGroote School of Medicine, McMaster University, Hamilton, ON, the Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, AB (T.P., J.M.S.), the Department of Hematology/Oncology, Centre Hospitalier de l'Université de Montreal, Montreal (N.B.), and the Department of Hematology/Oncology, Hôpital Régional de Saint-Jérôme, St. Jerome, QC (M.-C.L.) - all in Canada.
Arnold DM; From the Departments of Medicine (A.B., D.M.A., T.E.W., J.W.S., Z.A.A.A.M., A.S., J.G.K., I.N.) and Pathology and Molecular Medicine (A.B., T.E.W.), Michael G. DeGroote School of Medicine, McMaster University, Hamilton, ON, the Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, AB (T.P., J.M.S.), the Department of Hematology/Oncology, Centre Hospitalier de l'Université de Montreal, Montreal (N.B.), and the Department of Hematology/Oncology, Hôpital Régional de Saint-Jérôme, St. Jerome, QC (M.-C.L.) - all in Canada.
Warkentin TE; From the Departments of Medicine (A.B., D.M.A., T.E.W., J.W.S., Z.A.A.A.M., A.S., J.G.K., I.N.) and Pathology and Molecular Medicine (A.B., T.E.W.), Michael G. DeGroote School of Medicine, McMaster University, Hamilton, ON, the Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, AB (T.P., J.M.S.), the Department of Hematology/Oncology, Centre Hospitalier de l'Université de Montreal, Montreal (N.B.), and the Department of Hematology/Oncology, Hôpital Régional de Saint-Jérôme, St. Jerome, QC (M.-C.L.) - all in Canada.
Smith JW; From the Departments of Medicine (A.B., D.M.A., T.E.W., J.W.S., Z.A.A.A.M., A.S., J.G.K., I.N.) and Pathology and Molecular Medicine (A.B., T.E.W.), Michael G. DeGroote School of Medicine, McMaster University, Hamilton, ON, the Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, AB (T.P., J.M.S.), the Department of Hematology/Oncology, Centre Hospitalier de l'Université de Montreal, Montreal (N.B.), and the Department of Hematology/Oncology, Hôpital Régional de Saint-Jérôme, St. Jerome, QC (M.-C.L.) - all in Canada.
Pannu T; From the Departments of Medicine (A.B., D.M.A., T.E.W., J.W.S., Z.A.A.A.M., A.S., J.G.K., I.N.) and Pathology and Molecular Medicine (A.B., T.E.W.), Michael G. DeGroote School of Medicine, McMaster University, Hamilton, ON, the Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, AB (T.P., J.M.S.), the Department of Hematology/Oncology, Centre Hospitalier de l'Université de Montreal, Montreal (N.B.), and the Department of Hematology/Oncology, Hôpital Régional de Saint-Jérôme, St. Jerome, QC (M.-C.L.) - all in Canada.
Shrum JM; From the Departments of Medicine (A.B., D.M.A., T.E.W., J.W.S., Z.A.A.A.M., A.S., J.G.K., I.N.) and Pathology and Molecular Medicine (A.B., T.E.W.), Michael G. DeGroote School of Medicine, McMaster University, Hamilton, ON, the Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, AB (T.P., J.M.S.), the Department of Hematology/Oncology, Centre Hospitalier de l'Université de Montreal, Montreal (N.B.), and the Department of Hematology/Oncology, Hôpital Régional de Saint-Jérôme, St. Jerome, QC (M.-C.L.) - all in Canada.
Al Maqrashi ZAA; From the Departments of Medicine (A.B., D.M.A., T.E.W., J.W.S., Z.A.A.A.M., A.S., J.G.K., I.N.) and Pathology and Molecular Medicine (A.B., T.E.W.), Michael G. DeGroote School of Medicine, McMaster University, Hamilton, ON, the Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, AB (T.P., J.M.S.), the Department of Hematology/Oncology, Centre Hospitalier de l'Université de Montreal, Montreal (N.B.), and the Department of Hematology/Oncology, Hôpital Régional de Saint-Jérôme, St. Jerome, QC (M.-C.L.) - all in Canada.
Shroff A; From the Departments of Medicine (A.B., D.M.A., T.E.W., J.W.S., Z.A.A.A.M., A.S., J.G.K., I.N.) and Pathology and Molecular Medicine (A.B., T.E.W.), Michael G. DeGroote School of Medicine, McMaster University, Hamilton, ON, the Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, AB (T.P., J.M.S.), the Department of Hematology/Oncology, Centre Hospitalier de l'Université de Montreal, Montreal (N.B.), and the Department of Hematology/Oncology, Hôpital Régional de Saint-Jérôme, St. Jerome, QC (M.-C.L.) - all in Canada.
Lessard MC; From the Departments of Medicine (A.B., D.M.A., T.E.W., J.W.S., Z.A.A.A.M., A.S., J.G.K., I.N.) and Pathology and Molecular Medicine (A.B., T.E.W.), Michael G. DeGroote School of Medicine, McMaster University, Hamilton, ON, the Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, AB (T.P., J.M.S.), the Department of Hematology/Oncology, Centre Hospitalier de l'Université de Montreal, Montreal (N.B.), and the Department of Hematology/Oncology, Hôpital Régional de Saint-Jérôme, St. Jerome, QC (M.-C.L.) - all in Canada.
Blais N; From the Departments of Medicine (A.B., D.M.A., T.E.W., J.W.S., Z.A.A.A.M., A.S., J.G.K., I.N.) and Pathology and Molecular Medicine (A.B., T.E.W.), Michael G. DeGroote School of Medicine, McMaster University, Hamilton, ON, the Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, AB (T.P., J.M.S.), the Department of Hematology/Oncology, Centre Hospitalier de l'Université de Montreal, Montreal (N.B.), and the Department of Hematology/Oncology, Hôpital Régional de Saint-Jérôme, St. Jerome, QC (M.-C.L.) - all in Canada.
Kelton JG; From the Departments of Medicine (A.B., D.M.A., T.E.W., J.W.S., Z.A.A.A.M., A.S., J.G.K., I.N.) and Pathology and Molecular Medicine (A.B., T.E.W.), Michael G. DeGroote School of Medicine, McMaster University, Hamilton, ON, the Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, AB (T.P., J.M.S.), the Department of Hematology/Oncology, Centre Hospitalier de l'Université de Montreal, Montreal (N.B.), and the Department of Hematology/Oncology, Hôpital Régional de Saint-Jérôme, St. Jerome, QC (M.-C.L.) - all in Canada.
Nazy I; From the Departments of Medicine (A.B., D.M.A., T.E.W., J.W.S., Z.A.A.A.M., A.S., J.G.K., I.N.) and Pathology and Molecular Medicine (A.B., T.E.W.), Michael G. DeGroote School of Medicine, McMaster University, Hamilton, ON, the Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, AB (T.P., J.M.S.), the Department of Hematology/Oncology, Centre Hospitalier de l'Université de Montreal, Montreal (N.B.), and the Department of Hematology/Oncology, Hôpital Régional de Saint-Jérôme, St. Jerome, QC (M.-C.L.) - all in Canada.
Pokaż więcej
Źródło :
The New England journal of medicine [N Engl J Med] 2021 Aug 19; Vol. 385 (8), pp. 720-728. Date of Electronic Publication: 2021 Jun 09.
Typ publikacji :
Case Reports; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Immunoglobulins, Intravenous*
COVID-19 Vaccines/*adverse effects
Thrombocytopenia/*therapy
Thrombosis/*therapy
Aged ; Female ; Fibrin Fibrinogen Degradation Products/analysis ; Fibrinogen/analysis ; Heparin/pharmacology ; Humans ; Male ; Middle Aged ; Platelet Count ; Platelet Factor 4/pharmacology ; Serotonin/blood ; Thrombocytopenia/blood ; Thrombocytopenia/etiology ; Thrombosis/etiology ; Thrombosis/immunology
Czasopismo naukowe
Tytuł :
Guillain-Barré syndrome as the first presentation of human immunodeficiency virus infection.
Autorzy :
Lopes M; Department of Infectious Diseases, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal. .
Marques P; Department of Neurology, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal.
Silva B; Department of Neurology, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal.
Cruz G; Department of Infectious Diseases, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal.
Serra JE; Department of Infectious Diseases, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal.
Ferreira E; Department of Infectious Diseases, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal.
Alves H; Department of Infectious Diseases, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal.
da Cunha JS; Department of Infectious Diseases, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal.
Pokaż więcej
Źródło :
BMC neurology [BMC Neurol] 2021 Aug 18; Vol. 21 (1), pp. 321. Date of Electronic Publication: 2021 Aug 18.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Antiretroviral Therapy, Highly Active*
Primary Dysautonomias*
Adrenal Cortex Hormones/*therapeutic use
Guillain-Barre Syndrome/*complications
HIV Infections/*drug therapy
Immunoglobulins, Intravenous/*therapeutic use
Muscle Weakness/*etiology
Adrenal Cortex Hormones/administration & dosage ; Guillain-Barre Syndrome/diagnosis ; Guillain-Barre Syndrome/drug therapy ; HIV Infections/complications ; Humans ; Immunoglobulins, Intravenous/administration & dosage ; Male ; Middle Aged ; Muscle Weakness/drug therapy ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Thromboembolic complications following intravenous immunoglobulin therapy in immune-mediated neurological disorders.
Autorzy :
Chun W; Department of Neurology, Inha University Hospital, Incheon, Republic of Korea.
Kim Y; Department of Neurology, Inha University Hospital, Incheon, Republic of Korea.
Park SH; Department of Neurology, Inha University Hospital, Incheon, Republic of Korea; Department of Critical Care Medicine, Inha University Hospital, Incheon, Republic of Korea.
Choi SJ; Department of Neurology, Inha University Hospital, Incheon, Republic of Korea; Department of Neurology, Seoul National University Hospital, Seoul, Republic of Korea; Biomedical Research Institute, Seoul National University Hospital, Seoul, Republic of Korea. Electronic address: .
Pokaż więcej
Źródło :
Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia [J Clin Neurosci] 2021 Aug; Vol. 90, pp. 311-316. Date of Electronic Publication: 2021 Jun 21.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Immunization, Passive/*adverse effects
Immunoglobulins, Intravenous/*adverse effects
Nervous System Diseases/*complications
Nervous System Diseases/*therapy
Thromboembolism/*complications
Aged, 80 and over ; Critical Illness ; Female ; Guillain-Barre Syndrome/complications ; Guillain-Barre Syndrome/therapy ; Humans ; Immunoglobulins, Intravenous/therapeutic use ; Ischemic Stroke/etiology ; Male ; Middle Aged ; Myasthenia Gravis/complications ; Myasthenia Gravis/therapy ; Pulmonary Embolism/etiology ; Retrospective Studies
Czasopismo naukowe
Tytuł :
Effects of compaction and storage conditions on stability of intravenous immunoglobulin - Implication on developing oral tablets of biologics.
Autorzy :
Lu Y; Department of Pharmaceutical Sciences, School of Pharmacy, University of Maryland, Baltimore, MN 21201, United States.
Wang C; Pharmaceutical Materials Science and Engineering Laboratory, Department of Pharmaceutics, University of Minnesota, Minneapolis, MN 55455, United States.
Jiang B; Department of Pharmaceutical Sciences, School of Pharmacy, University of Maryland, Baltimore, MN 21201, United States.
Sun CC; Pharmaceutical Materials Science and Engineering Laboratory, Department of Pharmaceutics, University of Minnesota, Minneapolis, MN 55455, United States. Electronic address: .
Hoag SW; Department of Pharmaceutical Sciences, School of Pharmacy, University of Maryland, Baltimore, MN 21201, United States. Electronic address: .
Pokaż więcej
Źródło :
International journal of pharmaceutics [Int J Pharm] 2021 Jul 15; Vol. 604, pp. 120737. Date of Electronic Publication: 2021 May 26.
Typ publikacji :
Journal Article
MeSH Terms :
Biological Products*
Immunoglobulins, Intravenous*
Chromatography, Gel ; Circular Dichroism ; Drug Stability ; Humans ; Spectroscopy, Fourier Transform Infrared ; Tablets
Czasopismo naukowe
Tytuł :
Population pharmacokinetic modelling of intravenous immunoglobulin in patients with predominantly antibody deficiencies.
Autorzy :
Lee JL; Centre for Quality Management of Medicines, Faculty of Pharmacy, Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia.; Department of Pharmacy, Tengku Ampuan Rahimah Hospital, Ministry of Health Malaysia, Klang, Selangor Darul Ehsan, Malaysia.
Mohd Saffian S; Centre for Quality Management of Medicines, Faculty of Pharmacy, Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia.
Makmor-Bakry M; Centre for Quality Management of Medicines, Faculty of Pharmacy, Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia.
Islahudin F; Centre for Quality Management of Medicines, Faculty of Pharmacy, Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia.
Alias H; Department of Pediatrics, UKM Medical Centre, Faculty of Medicine, Universiti Kebangsaan Malaysia, Cheras, Kuala Lumpur, Malaysia.
Noh LM; Department of Pediatrics, Tunku Azizah Women & Children Hospital, Ministry of Health Malaysia, Kuala Lumpur, Malaysia.
Ismail IH; Department of Pediatrics, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, Serdang, Selangor Darul Ehsan, Malaysia.
Mohamed Shah N; Centre for Quality Management of Medicines, Faculty of Pharmacy, Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia.
Pokaż więcej
Źródło :
British journal of clinical pharmacology [Br J Clin Pharmacol] 2021 Jul; Vol. 87 (7), pp. 2956-2966. Date of Electronic Publication: 2021 Jan 11.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Immunoglobulins, Intravenous*/pharmacokinetics
Models, Biological*
Administration, Intravenous ; Computer Simulation ; Humans ; Monte Carlo Method
Czasopismo naukowe
Tytuł :
Meflin defines mesenchymal stem cells and/or their early progenitors with multilineage differentiation capacity.
Autorzy :
Hara A; Department of Pathology, Nagoya University Graduate School of Medicine, Nagoya, Japan.; Department of Cardiology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Kato K; Department of Cardiology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Ishihara T; Department of Pathology, Nagoya University Graduate School of Medicine, Nagoya, Japan.; Department of Cardiology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Kobayashi H; Department of Pathology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Asai N; Department of Pathology, Fujita Health University, Toyoake, Japan.
Mii S; Department of Pathology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Shiraki Y; Department of Pathology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Miyai Y; Department of Pathology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Ando R; Department of Pathology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Mizutani Y; Department of Pathology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Iida T; Department of Pathology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Takefuji M; Department of Cardiology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Murohara T; Department of Cardiology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Takahashi M; International Center for Cell and Gene Therapy, Fujita Health University, Toyoake, Japan.
Enomoto A; Department of Pathology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Pokaż więcej
Źródło :
Genes to cells : devoted to molecular & cellular mechanisms [Genes Cells] 2021 Jul; Vol. 26 (7), pp. 495-512. Date of Electronic Publication: 2021 May 17.
Typ publikacji :
Journal Article
MeSH Terms :
Cell Differentiation*
Cell Lineage*
Immunoglobulins/*metabolism
Mesenchymal Stem Cells/*metabolism
Adipocytes/cytology ; Adipocytes/metabolism ; Animals ; Chondrocytes/cytology ; Chondrocytes/metabolism ; Immunoglobulins/genetics ; Mesenchymal Stem Cells/cytology ; Mice ; Mice, Inbred C57BL ; Muscle Cells/cytology ; Muscle Cells/metabolism ; Osteocytes/cytology ; Osteocytes/metabolism
Czasopismo naukowe
Tytuł :
Boolean analysis of the transcriptomic data to identify novel biomarkers of IVIG response.
Autorzy :
Rambabu N; Institut National de la Santé et de la Recherche Médicale, Centre de Recherche des Cordeliers, Sorbonne Université, Université de Paris, F-75006 Paris, France.
Mathew MJ; École D'ingénieur Généraliste en Informatique et Technologies du Numérique, 30-32 Avenue de la République, F-94800 Villejuif, France.
Kaveri SV; Institut National de la Santé et de la Recherche Médicale, Centre de Recherche des Cordeliers, Sorbonne Université, Université de Paris, F-75006 Paris, France.
Bayry J; Institut National de la Santé et de la Recherche Médicale, Centre de Recherche des Cordeliers, Sorbonne Université, Université de Paris, F-75006 Paris, France; Indian Institute of Technology Palakkad, Palakkad 678623, India. Electronic address: .
Pokaż więcej
Źródło :
Autoimmunity reviews [Autoimmun Rev] 2021 Jul; Vol. 20 (7), pp. 102850. Date of Electronic Publication: 2021 May 07.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Immunoglobulins, Intravenous*/therapeutic use
Mucocutaneous Lymph Node Syndrome*/diagnosis
Mucocutaneous Lymph Node Syndrome*/drug therapy
Mucocutaneous Lymph Node Syndrome*/genetics
Biomarkers ; Humans ; Infant ; Retrospective Studies ; Transcriptome
Czasopismo naukowe
Tytuł :
The preparation of N-IgY targeting SARS-CoV-2 and its immunomodulation to IFN-γ production in vitro.
Autorzy :
Lyu J; State Key Laboratory of Oral Diseases, National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu 610041, China; Nanjing Stomatological Hospital, Medical School of Nanjing University, Nanjing 210008, China.
Bao L; State Key Laboratory of Oral Diseases, National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu 610041, China.
Shen X; State Key Laboratory of Oral Diseases, National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu 610041, China.
Yan C; State Key Laboratory of Oral Diseases, National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu 610041, China.
Zhang C; State Key Laboratory of Oral Diseases, National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu 610041, China.
Wei W; State Key Laboratory of Oral Diseases, National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu 610041, China.
Yang Y; State Key Laboratory of Oral Diseases, National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu 610041, China.
Li J; State Key Laboratory of Oral Diseases, National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu 610041, China.
Dong J; Department of Pulmonary and Critical Care Medicine, West China Hospital, Sichuan University, Chengdu 610041, China.
Xiao L; State Key Laboratory of Oral Diseases, National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu 610041, China.
Zhou X; State Key Laboratory of Oral Diseases, National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu 610041, China. Electronic address: .
Li Y; State Key Laboratory of Oral Diseases, National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu 610041, China. Electronic address: .
Pokaż więcej
Źródło :
International immunopharmacology [Int Immunopharmacol] 2021 Jul; Vol. 96, pp. 107797. Date of Electronic Publication: 2021 May 19.
Typ publikacji :
Journal Article
MeSH Terms :
Antibodies/*immunology
Antiviral Agents/*immunology
COVID-19/*immunology
Immunoglobulins/*immunology
Immunologic Factors/*immunology
Interferon-gamma/*metabolism
SARS-CoV-2/*immunology
Animals ; Antibodies/pharmacology ; Antiviral Agents/pharmacology ; COVID-19/therapy ; Chickens ; Drug Development ; Egg Yolk/chemistry ; Egg Yolk/metabolism ; Humans ; Immunity ; Immunoglobulins/pharmacology ; Immunologic Factors/pharmacology ; Immunomodulation ; In Vitro Techniques ; Nucleocapsid Proteins/immunology ; Nucleocapsid Proteins/metabolism ; SARS-CoV-2/metabolism
Czasopismo naukowe
Tytuł :
Fetal and maternal outcome after hyperimmunoglobulin administration for prevention of maternal-fetal transmission of cytomegalovirus during pregnancy: retrospective cohort analysis.
Autorzy :
Seidel V; Department of Obstetrics, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität Zu Berlin, and Berlin Institute of Health, Augustenburger Platz 1, 13353, Berlin, Germany. .
Hackelöer M; Department of Obstetrics, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität Zu Berlin, and Berlin Institute of Health, Augustenburger Platz 1, 13353, Berlin, Germany.
Rancourt RC; Division of 'Experimental Obstetrics', Clinic of Obstetrics, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität Zu Berlin, and Berlin Institute of Health, Campus Virchow-Klinikum, Berlin, Germany.
Henrich W; Department of Obstetrics, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität Zu Berlin, and Berlin Institute of Health, Augustenburger Platz 1, 13353, Berlin, Germany.
Siedentopf JP; Department of Obstetrics, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität Zu Berlin, and Berlin Institute of Health, Augustenburger Platz 1, 13353, Berlin, Germany.
Pokaż więcej
Źródło :
Archives of gynecology and obstetrics [Arch Gynecol Obstet] 2020 Dec; Vol. 302 (6), pp. 1353-1359. Date of Electronic Publication: 2020 Aug 04.
Typ publikacji :
Comparative Study; Journal Article; Observational Study
MeSH Terms :
Amniotic Fluid/*virology
Cytomegalovirus/*immunology
Cytomegalovirus Infections/*diagnosis
Cytomegalovirus Infections/*transmission
Immunoglobulins/*administration & dosage
Infectious Disease Transmission, Vertical/*prevention & control
Pregnancy Complications, Infectious/*diagnosis
Pregnancy Complications, Infectious/*virology
Adult ; Antibodies, Viral ; Cohort Studies ; Cytomegalovirus Infections/drug therapy ; Cytomegalovirus Infections/prevention & control ; Female ; Fetal Diseases/diagnosis ; Humans ; Immunoglobulins/therapeutic use ; Immunoglobulins, Intravenous ; Infant ; Infant, Newborn ; Pregnancy ; Pregnancy Complications, Infectious/drug therapy ; Pregnancy Complications, Infectious/prevention & control ; Pregnancy Outcome/epidemiology ; Prenatal Care ; Retrospective Studies
Czasopismo naukowe
Tytuł :
Comparison of risk scores for predicting intravenous immunoglobulin resistance in Taiwanese patients with Kawasaki disease.
Autorzy :
Huang CN; Department of Pediatrics, Heping-Fuyou Branch, Taipei City Hospital, Taipei, Taiwan.
Wu FF; Department of Pediatrics, Heping-Fuyou Branch, Taipei City Hospital, Taipei, Taiwan.
Chang YM; Department of Pediatrics, Heping-Fuyou Branch, Taipei City Hospital, Taipei, Taiwan.
Huang HC; Department of Pediatrics, Heping-Fuyou Branch, Taipei City Hospital, Taipei, Taiwan.
Lin MT; Department of Pediatrics, National Taiwan University Children's Hospital, Taipei, Taiwan. Electronic address: .
Wang JK; Department of Pediatrics, National Taiwan University Children's Hospital, Taipei, Taiwan.
Wu MH; Department of Pediatrics, National Taiwan University Children's Hospital, Taipei, Taiwan.
Pokaż więcej
Źródło :
Journal of the Formosan Medical Association = Taiwan yi zhi [J Formos Med Assoc] 2021 Oct; Vol. 120 (10), pp. 1884-1889. Date of Electronic Publication: 2020 Dec 23.
Typ publikacji :
Journal Article
MeSH Terms :
Immunoglobulins, Intravenous*/therapeutic use
Mucocutaneous Lymph Node Syndrome*/drug therapy
Child ; Drug Resistance ; Humans ; Infant ; Retrospective Studies ; Risk Assessment ; Risk Factors
Czasopismo naukowe
Tytuł :
Mitigating the risk of COVID-19 exposure by transitioning from clinic-based to home-based immune globulin infusion.
Autorzy :
Perreault S; Department of Pharmacy, Yale New Haven Health, New Haven, CT, USA.
Schiffer M; Department of Pharmacy, Yale New Haven Health, New Haven, CT, USA.
Clinchy-Jarmoszko V; Department of Nursing, Yale New Haven Health, New Haven, CT, USA.
Bocchetta N; Department of Nursing, Yale New Haven Health, New Haven, CT, USA.
Barbarotta L; Department of Nursing, Yale New Haven Health, New Haven, CT, USA.
Abdelghany O; Department of Pharmacy, Yale New Haven Health, New Haven, CT, USA.
Foss F; Department of Hematology, Yale School of Medicine, New Haven, CT, and Yale New Haven Health, New Haven, CT, USA.
Huntington S; Department of Hematology, Yale School of Medicine, New Haven, CT, and Yale New Haven Health, New Haven, CT, USA.
Seropian S; Department of Hematology, Yale School of Medicine, New Haven, CT, and Yale New Haven Health, New Haven, CT, USA.
Isufi I; Department of Hematology, Yale School of Medicine, New Haven, CT, and Yale New Haven Health, New Haven, CT, USA.
Pokaż więcej
Źródło :
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists [Am J Health Syst Pharm] 2021 Jun 07; Vol. 78 (12), pp. 1112-1117.
Typ publikacji :
Journal Article
MeSH Terms :
Immunocompromised Host*
COVID-19/*prevention & control
Home Care Services/*organization & administration
Immunoglobulins, Intravenous/*administration & dosage
Adult ; Aged ; Aged, 80 and over ; Ambulatory Care Facilities/organization & administration ; Female ; Humans ; Immunoglobulins, Intravenous/adverse effects ; Immunoglobulins, Intravenous/economics ; Male ; Middle Aged ; Patient Care Team ; Patient Satisfaction ; SARS-CoV-2 ; United States
Czasopismo naukowe
Tytuł :
On the use of intravenous immunoglobulins for the treatment of the antiphospholipid syndrome - A systematic review and meta-analysis.
Autorzy :
Lalmahomed TA; Department of Rheumatology and Clinical Immunology, University Medical Center Utrecht, Utrecht, the Netherlands.
Walter IJ; Department of Gynaecology and Obstetrics, Wilhelmina Children's Hospital/University Medical Center Utrecht, Utrecht, the Netherlands.
Lely AT; Department of Gynaecology and Obstetrics, Wilhelmina Children's Hospital/University Medical Center Utrecht, Utrecht, the Netherlands.
Bloemenkamp KWM; Department of Gynaecology and Obstetrics, Wilhelmina Children's Hospital/University Medical Center Utrecht, Utrecht, the Netherlands.
Kooiman J; Department of Gynaecology and Obstetrics, Wilhelmina Children's Hospital/University Medical Center Utrecht, Utrecht, the Netherlands.
Limper M; Department of Rheumatology and Clinical Immunology, University Medical Center Utrecht, Utrecht, the Netherlands. Electronic address: .
Pokaż więcej
Źródło :
Autoimmunity reviews [Autoimmun Rev] 2021 Jun; Vol. 20 (6), pp. 102828. Date of Electronic Publication: 2021 Apr 15.
Typ publikacji :
Letter; Meta-Analysis; Systematic Review
MeSH Terms :
Antiphospholipid Syndrome*/drug therapy
Immunoglobulins, Intravenous*/therapeutic use
Antibodies, Antiphospholipid ; Humans ; beta 2-Glycoprotein I
Raport
Tytuł :
Application of intravenous immunoglobulin (IVIG) to modulate inflammation in critical COVID-19 - A theoretical perspective.
Autorzy :
Yaqinuddin A; Alfaisal University, Riyadh, Saudi Arabia.
Ambia AR; Alfaisal University, Riyadh, Saudi Arabia.
Elgazzar TA; Alfaisal University, Riyadh, Saudi Arabia.
AlSaud MBM; Alfaisal University, Riyadh, Saudi Arabia.
Kashir J; Alfaisal University, Riyadh, Saudi Arabia; Department of Comparative Medicine, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia. Electronic address: .
Pokaż więcej
Źródło :
Medical hypotheses [Med Hypotheses] 2021 Jun; Vol. 151, pp. 110592. Date of Electronic Publication: 2021 Apr 09.
Typ publikacji :
Journal Article
MeSH Terms :
COVID-19*
Immunoglobulins, Intravenous*
Aged ; Humans ; Inflammation ; RNA, Viral ; SARS-CoV-2
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies